258 related articles for article (PubMed ID: 1323814)
1. Platinum/oral etoposide therapy in non-small cell lung cancer.
Furuse K
Oncology; 1992; 49 Suppl 1():63-9; discussion 70. PubMed ID: 1323814
[TBL] [Abstract][Full Text] [Related]
2. Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.
Greco FA; Murphy PB; Hainsworth JD; Hande KR; Johnson DH
Oncology; 1992; 49 Suppl 1():34-8; discussion 39. PubMed ID: 1323810
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
Planting A; Kho S; van der Burg M; Goey H; Schellens J; van den Bent M; van der Gaast A; de Boer-Dennert M; Stoter G; Verweij J
Cancer Chemother Pharmacol; 1997; 40(4):347-52. PubMed ID: 9225954
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
Johnson FM; Kurie JM; Peeples BO; Lee JJ; Feng L; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer.
Fukuoka M; Masuda N; Negoro S; Takada M; Kudoh S; Kusunoki Y; Matsui K; Takifuji N; Tachikawa A; Kawahara M
Cancer; 1991 Jul; 68(2):284-8. PubMed ID: 2070326
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer.
Boyer MJ; Zalcberg J; Olver IN; Millward MJ; Richardson G; McKeage MJ
Ann Oncol; 1997 May; 8(5):485-9. PubMed ID: 9233529
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer.
Murphy PB; Hainsworth JD; Greco FA; Hande KR; DeVore RF; Johnson DH
Cancer; 1992 Jan; 69(2):370-5. PubMed ID: 1309432
[TBL] [Abstract][Full Text] [Related]
10. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
Bonomi P; Kim K; Fairclough D; Cella D; Kugler J; Rowinsky E; Jiroutek M; Johnson D
J Clin Oncol; 2000 Feb; 18(3):623-31. PubMed ID: 10653877
[TBL] [Abstract][Full Text] [Related]
13. [Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
Fujita J; Morikawa N; Yamaji Y; Kubo A; Takigawa K; Yamagishi Y; Fujita T; Shiotani T; Takahara J; Irino S
Gan To Kagaku Ryoho; 1992 Jun; 19(6):849-54. PubMed ID: 1318697
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
Greco FA; Stroup SL; Gray JR; Hainsworth JD
J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide].
Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kuno K
Gan To Kagaku Ryoho; 1994 Jan; 21(1):53-8. PubMed ID: 8291916
[TBL] [Abstract][Full Text] [Related]
16. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory combination chemotherapy with oral etoposide and cisplatin for advanced non small cell lung carcinoma patients. A phase II study.
Focan C; Le Hung S; Frere MH; Schallier D
Anticancer Res; 1986; 6(5):977-81. PubMed ID: 3026238
[TBL] [Abstract][Full Text] [Related]
18. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
Bunn PA; Kelly K
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.
Johnson DH; Hainsworth JD; DeVore R; Hande KR; Greco FA
Oncology; 1992; 49 Suppl 1():57-61; discussion 61-2. PubMed ID: 1323813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
